Residual Plasma Viremia and Infectious HIV-1 Recovery from Resting Memory CD4 Cells in Patients on Antiretroviral Therapy: Results from ACTG A5173

Eitemau Tebyg

• Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1–Infected Adults Receiving Long-term Antiretroviral Therapy
  gan: Riddler, Sharon A., et al.
  Cyhoeddwyd: (2016)
• Predictors of Residual Viremia in Patients on Long-term Suppressive Antiretroviral Therapy
  gan: Zheng, Lu, et al.
  Cyhoeddwyd: (2012)
• No Evidence for Decay of the Latent Reservoir in HIV-1–Infected Patients Receiving Intensive Enfuvirtide-Containing Antiretroviral Therapy
  gan: Gandhi, Rajesh T., et al.
  Cyhoeddwyd: (2010)
• Continuing or adding IL-2 in patients treated with antiretroviral therapy (ACTG Protocol A5051, a rollover trial of ACTG Protocol A328)
  gan: Bosch, Ronald J, et al.
  Cyhoeddwyd: (2010)
• HIV-1 DNA Decay Dynamics in Blood During More Than a Decade of Suppressive Antiretroviral Therapy
  gan: Besson, Guillaume J., et al.
  Cyhoeddwyd: (2014)